Retinitis pigmentosa: open trials in Germany

• NCT05878860

  A Phase 1/2/3 Study of ATSN-201 Gene Therapy in Subjects with RS1-Associated X linked Retinoschisis

  Trial Treatment · Phase 3 · Atsena Therapeutics Inc.

  Ludwig-Maximilians-Universitaet Muenchen, Munich · Universitaetsklinikum Tuebingen AöR, Tuebingen

  Registry updated 2026-10-19

• NCT07548944

  Observational Study to Investigate the Short-term Effects of Transcorneal Electrical Stimulation on Visual Performance

  Research · Okuvision GmbH

  Augenzentrum Frankfurt Prof. Koch GmbH, Frankfurt am Main

  Registry updated 2026-05-01

• NCT05809635

  Study of BEST1 Vitelliform Macular Dystrophy

  Research · Columbia University

  Eberhard Karls University Tubingen, Tübingen

  Registry updated 2025-07-30

• NCT07056738

  Prospective Exploratory Cohort Study on Ganglion Cell Degeneration in Retinitis Pigmentosa Patients

  Research · University Medical Center Goettingen

  EKFZ Else Kroener Fresenius Center for Optogenetic Therapies, University Medical Center Goettingen, Göttingen

  Registry updated 2025-07-09

• NCT06982417

  InsightRP2 Registry

  Research · University of Göttingen

  University Medicine Gottingen, Göttingen

  Registry updated 2025-05-21

• NCT06291935

  Safety and Tolerability of Intravitreal Administration of VG901 in Patients With Retinitis Pigmentosa Due to Mutations in the CNGA1 Gene

  Trial Treatment · Phase 1 · VeonGen Therapeutics GmbH

  Ludwig-Maximilians-Universitaet Muenchen, Munich · Universitaetsklinikum Tuebingen AöR, Tuebingen

  Registry updated 2025-03-28

All Retinitis pigmentosa trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error